Evidence map›Paper›PMID 37626816›Full record

ArticleBiomedicines2023

Induction of Skin Cancer by Long-Term Blue Light Irradiation.

Keiichi Hiramoto, Sayaka Kubo, Keiko Tsuji, Daijiro Sugiyama, Hideo Hamano

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Photocarcinogenesis of the skin: Current status and future trends.The Kaohsiung journal of medical sciences · 2025
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Keiichi HiramotoDepartment of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka 513-8670, Japan.
Sayaka KuboResearch Department, Daiichi Sankyo Healthcare Co., Ltd., Chuo-ku, Tokyo 140-8170, Japan.ORCID 0000-0003-0511-3787
Keiko TsujiResearch Department, Daiichi Sankyo Healthcare Co., Ltd., Chuo-ku, Tokyo 140-8170, Japan.
Daijiro SugiyamaResearch Department, Daiichi Sankyo Healthcare Co., Ltd., Chuo-ku, Tokyo 140-8170, Japan.
Hideo HamanoResearch Department, Daiichi Sankyo Healthcare Co., Ltd., Chuo-ku, Tokyo 140-8170, Japan.
Daiichi-Sankyo (Japan) · JPSuzuka University of Medical Science · JP

Funding

JSPS KAKENHI grant 23K06074
6 · The paper itself

Abstract

Presently, people are not only exposed to sunlight but also to a large amount of blue light from personal computers and smartphones. This blue light has various effects on the living body. However, its effect on the induction of skin cancer is unknown. In this study, we investigated the induction of skin cancer by long-term blue light irradiation. Hairless mice were irradiated with blue light (LED; peak emission 479 nm) every day for one year, and a control was irradiated with white light (LED), green light (LED; peak emission 538 nm), and red light (LED; peak emission 629 nm) for one year, respectively. Skin cancer was induced only in the mice exposed to blue light. Long-term blue light irradiation also increased the migration of neutrophils and macrophages involved in carcinogenesis in the skin. In neutrophils, an increased expression of citH3 and PAD4 was observed, suggesting the possibility of NETosis. Conversely, in macrophages, inflammatory macrophages (type 1 macrophages) increased and anti-inflammatory macrophages (type 2 macrophages) decreased due to continuous blue light irradiation. These findings suggest that long-term continuous irradiation with blue light induces neutrophil NETosis and an increase in type 1 macrophages, resulting in skin cancer.

Indexed as

blue lightmacrophageneutrophilskin cancer

Identifiers

PMID37626816
PMCPMC10452187
OpenAlexW4386026494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.